Bioregenx (BRGX) Net Equity Issued and Repurchased (2023)
Bioregenx (BRGX) posted quarterly Net Equity Issued and Repurchased of $527088.0 for Q4 2023, up 733.88% quarter-over-quarter from $63209.0 in Q3 2023.
Bioregenx (BRGX) Net Equity Issued and Repurchased (2023) Analysis & Trends
Bioregenx's Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $527088.0 for Q4 2023.
- In Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $527088.0; the TTM figure through Sep 2024 stood at $527088.0 (changed N/A YoY), while the FY2023 annual figure was $1.3 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2023 stood at $527088.0, up from $63209.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $527088.0 in Q4 2023, with the low at $63209.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 39.72 Bn | 32.40 Bn | 662.02 Mn | - |
| 2 | BrightSpring Health Services | 12.19 Bn | 11.64 Bn | 492.75 Mn | - |
| 3 | Healthequity | 8.79 Bn | 8.52 Bn | 256.31 Mn | - |
| 4 | 10x Genomics | 7.31 Bn | 6.76 Bn | 112.50 Mn | - |
| 5 | Hinge Health | 7.10 Bn | 6.71 Bn | 183.95 Mn | - |
| 6 | MiniMed | 5.66 Bn | 5.36 Bn | 480.00 Mn | - |
| 7 | Waystar Holding | 4.76 Bn | 4.56 Bn | 221.99 Mn | - |
| 8 | Doximity | 4.46 Bn | 3.77 Bn | 132.93 Mn | - |
| 9 | Heartflow | 3.66 Bn | 3.28 Bn | 53.19 Mn | - |
| 10 | Bioregenx | 9.72 Mn | 9.67 Mn | 348,288.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 527,088.00 |
| Dec 31, 2023 | 527,088.00 |
| Sep 30, 2023 | 63,209.00 |
| Sep 30, 2023 | 63,209.00 |
| Jun 30, 2023 | 414,105.00 |
| Jun 30, 2023 | 414,105.00 |
| Mar 31, 2023 | 337,739.00 |
| Mar 31, 2023 | 337,739.00 |